You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)與IFC深化合作 便利非洲以平價獲得高質藥品
復星醫藥(02196.HK)(600196.SH)宣布與國際金融公司(IFC)深化合作夥伴關係,IFC將向復星醫藥子公司提供兩筆總額達5,000萬歐元的貸款,以支持復星醫藥在科特迪瓦建立藥品生產設施和分銷中心。 根據規劃,復星醫藥將在科特迪瓦阿比讓附近建設一座抗瘧藥產品和抗生素產品的生產工廠。該項目工程計劃分三期進行,預計三期項目全部建成後,該園區年產能將達50億片。 復星醫藥董事長吳以芳表示,項目能獲IFC支持有助於集團在非洲實現藥品本地化生產和分銷。IFC非洲地區副總裁華曼德表示,IFC與復星醫藥的合作將提高西非當地的基礎藥物生產能力,令該地區的患者更容易獲得優質平價的藥品。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account